JPRN-UMIN000053929尚未招募Unknown
Prospective evaluation study of one-step technique during EUS-guided hepaticogastrostomy using a partially covered self-expandable metal stent with fine gauge stent delivery system - Prospective evaluation study of one-step technique during EUS-guided hepaticogastrostomy using a partially covered self-expandable metal stent with fine gauge stent delivery system
Osaka Medical and Pharmaceutical University0 个研究点目标入组 25 人开始时间: 2024年4月1日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1. total gastorectomy 2. ascites 3. pregnancy, risk of bleeding 4. denied to participate this study 5. Inadequate reasons which are considered by doctors
研究者
相似试验
尚未招募
Unknown
Role of musta aragwadhadi powder udwartana (churna massage) in childhood obesityCTRI/2024/07/069816national institute of ayurveda
招募中
不适用
To assess the efficacy and applicability of a single injection of Erector spinae plane in video assisted thoracoscopic surgeriesCTRI/2019/05/019413TATA MEMORIAL CENTRE
进行中(未招募)
1 期
Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children with Neurofibromatosis Type 1 (NF1) Related Plexiform Neurofibromas (PN)EUCTR2020-005648-52-ESAstraZeneca AB20
进行中(未招募)
1 期
Phase I Study to Assess the Effect of Food on the PK and GastrointestinalTolerability of Selumetinib in Adolescent Children with NeurofibromatosisType 1 (NF1) Related Plexiform Neurofibromas (PN)eurofibromatosis Type 1 (NF1) Related Plexiform Neurofibromas (PN)MedDRA version: 20.0Level: LLTClassification code 10029270Term: Neurofibromatosis, type 1 (von Recklinghausen's disease)System Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-005648-52-PLAstraZeneca AB20
尚未招募
3 期
: A clinical trial to study the effect of japapushpa formulation (asava kalpana) in management of mild iron deficiency anaemiaCTRI/2024/03/064155Sree Narayana Health Care Society
